Crossmark

Real life study of three years omalizumab in patients with difficult-to-control asthma

Crossref DOI link: https://doi.org/10.1016/j.aller.2013.11.008

Published Print: 2015-03

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

López Tiro, J. Jesús

Contreras, E. Angélica Contreras

del Pozo, M. Elena Ramírez

Gómez Vera, J.

Larenas Linnemann, D.
License Information

Text and Data Mining valid from 2015-03-01
More Information

This article is maintained by: Elsevier

Article Title: Real life study of three years omalizumab in patients with difficult-to-control asthma

Journal Title: Allergologia et Immunopathologia

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.aller.2013.11.008

Content Type: article

Copyright: Copyright © 2013 SEICAP. Published by Elsevier España, S.L. All rights reserved.